alexa Objective Evidence That Nerve Decompression Protects Against Foot Ulceration And Reulceration In Diabetic Polyneuropathy | OMICS International
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Scott Nickerson
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
Abstract
Introduction: Decompression of nerve at multiple fibro-osseous entrapment sites in the lower extremity of patients with diabetic sensorimotor polyneuropathy(DSPN) and subjective pain has been used for two decades with >80% success. It has been previously dismissed as a likely placebo and bias effect. But reports of objective benefits on occurrence of serious DSPN complications like balance, elevated perineural tissue pressure, nerve conduction velocity, muscle evoked potential, diabetic foot ulcer(DFU), reulceration, and amputation refute those critiques and urge a re-examination of the approach. This paper presents the 5 year long term ulcer recurrence results of a cohort of 75 legs with prior DFU and also compares prospectively the operated and contralateral leg ulceration risk of the 42 cases who had intact contralateral legs to compare with their unilateral ulcer and nerve decompression(ND) limb. Methods: Sixty-five DSPN cases with 1 or more healed DFUs in 75 limbs had ND of posterior tibial, common peroneal, and deep peroneal nerves at entrapment sites an average of 2.5 years after ulcer healing. All had numbness, extremity pain and a Tinel sign at an entrapment site. Limb healing status was determined at 5 years post-ND. For the 42 unilateral surgery cases primarily intact and with no subsequent intervention of revascularization or ND, the behavior of ND limbs was compared to the non-operated, intact contralateral leg for ulceration risk. Results: After 5 years reulceration risk for the operated limbs was 2.3%/year, representing a 90% reduction from risk reported in the literature. The prospective relative risk for non-operated control limbs from year 2 through year 5 was 5.5X that of the ND limbs. P = 0.048 Conclusions: These retrospective and prospective analyses indicate strong protection against ulceration and re-ulceration is provided for DSPN cases with pain and a prior DFU with multiple ND by external neurolysis at entrapment sites. This objective result is consistent with the multiple reports of subjective improvement in pain and sensibility as examined by the recent metaanalysis of Baltodano et al. Other objective outcome studies of ulceration prevention, balance recovery, diminutions of elevated perineural tissue pressures, nerve conduction velocity normalization, hospitalization for foot infection, intra-operative EMG improvement, and lower extremity amputation rates and risk are reviewed which show similar beneficial effects. The ND procedure, though still lacking reports of prospective, randomized control trials, has growing evidence of usefulness and deserves our consideration for the baleful complications of DSPN.
image PDF   |   image HTML
 

Relevant Topics

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version